These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Apoptosis rate and transcriptional response of pancreatic islets exposed to the PPAR gamma agonist Pioglitazone. Lamounier RN; Coimbra CN; White P; Costal FL; Oliveira LS; Giannella-Neto D; Kaestner KH; Corrêa-Giannella ML Diabetol Metab Syndr; 2013 Jan; 5(1):1. PubMed ID: 23298687 [TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone promotes PPARγ-dependent and -independent alterations in gene expression in mouse islets. Welters HJ; El Ouaamari A; Kawamori D; Meyer J; Hu J; Smith DM; Kulkarni RN Endocrinology; 2012 Oct; 153(10):4593-9. PubMed ID: 22807489 [TBL] [Abstract][Full Text] [Related]
6. Long-term exposure of INS-1 rat insulinoma cells to linoleic acid and glucose in vitro affects cell viability and function through mitochondrial-mediated pathways. Tuo Y; Wang D; Li S; Chen C Endocrine; 2011 Apr; 39(2):128-38. PubMed ID: 21161439 [TBL] [Abstract][Full Text] [Related]
7. Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. Cunha DA; Hekerman P; Ladrière L; Bazarra-Castro A; Ortis F; Wakeham MC; Moore F; Rasschaert J; Cardozo AK; Bellomo E; Overbergh L; Mathieu C; Lupi R; Hai T; Herchuelz A; Marchetti P; Rutter GA; Eizirik DL; Cnop M J Cell Sci; 2008 Jul; 121(Pt 14):2308-18. PubMed ID: 18559892 [TBL] [Abstract][Full Text] [Related]
8. Palmitate-induced beta-cell dysfunction is associated with excessive NO production and is reversed by thiazolidinedione-mediated inhibition of GPR40 transduction mechanisms. Meidute Abaraviciene S; Lundquist I; Galvanovskis J; Flodgren E; Olde B; Salehi A PLoS One; 2008 May; 3(5):e2182. PubMed ID: 18478115 [TBL] [Abstract][Full Text] [Related]
9. Expression and functional activity of PPARgamma in pancreatic beta cells. Welters HJ; McBain SC; Tadayyon M; Scarpello JH; Smith SA; Morgan NG Br J Pharmacol; 2004 Aug; 142(7):1162-70. PubMed ID: 15237101 [TBL] [Abstract][Full Text] [Related]
10. Troglitazone ameliorates lipotoxicity in the beta cell line INS-1 expressing PPAR gamma. Kawai T; Hirose H; Seto Y; Fujita H; Fujita H; Ukeda K; Saruta T Diabetes Res Clin Pract; 2002 May; 56(2):83-92. PubMed ID: 11891015 [TBL] [Abstract][Full Text] [Related]
11. [Studies on compounds with antioxidant activity--development of hypoglycemic agents, troglitazone (CS-045)]. Yoshioka T; Fujita T Yakugaku Zasshi; 1997 Sep; 117(9):597-610. PubMed ID: 9357328 [TBL] [Abstract][Full Text] [Related]
12. Troglitazone does not protect rat pancreatic beta cells against free fatty acid-induced cytotoxicity. Cnop M; Hannaert JC; Pipeleers DG Biochem Pharmacol; 2002 Apr; 63(7):1281-5. PubMed ID: 11960604 [TBL] [Abstract][Full Text] [Related]
13. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Shimabukuro M; Zhou YT; Levi M; Unger RH Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2498-502. PubMed ID: 9482914 [TBL] [Abstract][Full Text] [Related]
14. Troglitazone reduces free fatty acid-induced insulin resistance in perfused rat hindquarter. Mokuda O; Sakamoto Y Diabetes Metab; 1998 Sep; 24(4):362-4. PubMed ID: 9805648 [TBL] [Abstract][Full Text] [Related]
15. Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin. Willi SM; Kennedy A; Wallace P; Ganaway E; Rogers NL; Garvey WT Diabetes; 2002 Oct; 51(10):2895-902. PubMed ID: 12351424 [TBL] [Abstract][Full Text] [Related]